NCT00051142View on ClinicalTrials.gov

A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 2001

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
Glaucoma, Open-AngleOcular Hypertension
Interventions
DRUG

Travoprost

DRUG

Latanoprost

Trial Locations (1)

Unknown

Latin America, Fort Worth

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00051142 - A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) | Biotech Hunter | Biotech Hunter